Jane Street Group, LLC Aeterna Zentaris Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.17 - $0.37 $2,937 - $6,393	17,281 New	17,281 $3,000
Q2 2021 Aug 16, 2021	SELL	$0.83 - $1.14 $71,271 - $97,890	-85,869 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$0.51 - $3.34 $43,793 - $286,802	85,869 New	85,869 $98,000
Q4 2020 Feb 17, 2021	SELL	$0.3 - $0.44 $4,707 - $6,903	-15,690 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$0.34 - $0.55 $167 - $271	-493 Reduced 3.05%	15,690 $6,000
Q2 2020 Aug 17, 2020	BUY	$0.45 - $1.2 $7,282 - $19,419	16,183 New	16,183 $13,000
Q1 2019 May 16, 2019	SELL	$3.03 - $4.65 $30,521 - $46,839	-10,073 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.3 - $3.87 $13,094 - $38,982	10,073 New	10,073 $30,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.